Browse diseases

… killer presence (p<0.001) than the NCPR (figure 2).Conclusions NSCLC neoadjuvant ChIO antitumour response is primarily orchestrated …

…Background Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related deaths, often diag…

…roangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer. Neoplasia. 2013;15:133-142.Brownlie D, von Kries A, Valenzano …

…esothelin (MSLN) expression and five unbiasedly chosen mucinous CRC tissue blocks were also assessed.Results From 66 co-expressed t…

…Background Decision-making in non-small cell lung cancer (NSCLC) is complex and value-sensitive. A shared decision-makin…

…nal avoidance plans.Results 19F MRI scans were acquired from 12 NSCLC patients and RLCI maps created. 6 participants have had standar…

… lung cancer, non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC)？Methods Data of participants in this study were collecte…

…. While immune checkpoint inhibitors (ICIs) have revolutionized NSCLC treatment, a significant proportion of patients exhibit primary…

…rogrammed death receptor-1 inhibitor pembrolizumab for treating non-small cell lung cancer (NSCLC). Herein, we report the final efficacy, safety, and long…

…hibitor, and osimertinib in patients with EGFR-mutated advanced NSCLC.Methods Enrolled patients included Cohort 1 (previously progres…

… conferred both physiological and psychological improvements in chronic obstructive pulmonary disease, which may likely be transferable to NSCLC, as the two conditio…

… cell lung cancer (NSCLC). It was further performed independent NSCLC cohort, flow cytometry, multiplex immunohistochemistry, single-…